NeuroSense Therapeutics logo

NeuroSense Therapeutics jobs and careers

Herzliya, Tel Aviv District, Israel

About NeuroSense Therapeutics

NeuroSense Therapeutics is a clinical stage drug development company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.

Founded in 2017 by Alon Ben-Noon.

Founded
2017
Employees
11 to 50
Total funding
$10.1M
Headquarters
Herzliya

Leadership

The top of NeuroSense Therapeutics's org chart, with how many people report into each leader.

ABPhoto of Alon Ben-Noon

Alon Ben-Noon

Co-Founder & CEO

16 reports

OYPhoto of Oron Yacoby-Zeevi

Oron Yacoby-Zeevi

Chief Scientific Officer

4 reports

DSPhoto of Diana Shtossel

Diana Shtossel

Head of Regulatory Affairs

2 reports

KPPhoto of Keren Pushett

Keren Pushett

Head of HR

1 report

RGPhoto of Racheli Gueta

Racheli Gueta

Director Clinical Development

1 report

HBPhoto of Hagit Binder

Hagit Binder

General Manager

1 report

NRPhoto of Niva Russek-Blum

Niva Russek-Blum

Chief Technology Officer

OEPhoto of Or Eisenberg

Or Eisenberg

Chief Financial Officer

Board

MLPhoto of Mark Leuchtenberger

Mark Leuchtenberger

Chairman, Board of Directors

CCPhoto of Cary Claiborne

Cary Claiborne

Member Board Of Directors; Audit Committee Chair

YGPhoto of Yossi Gilgun-Sherki

Yossi Gilgun-Sherki

Scientific Advisory Board (SAB) Member

JSPhoto of Jeremy Shefner

Jeremy Shefner

Scientific Advisor

RMPhoto of Revital Mandil-Levin

Revital Mandil-Levin

Advisor

JRPhoto of Jeffrey Rosenfeld

Jeffrey Rosenfeld

Scientific Advisory Board Member

Jobs at NeuroSense Therapeutics

No open positions right now. Explore more companies on TheJobsMap.